LOX and breast cancer: In order to explore the biological properties of LOX without interference from other lysyl-oxidase family members, we knocked out the genes encoding the different lysyl-oxidases in MDA-MB-231 breast cancer cells by the introduction of frame shift mutations into the first or second exons of these genes using CRISPR/Cas9.